MALAT1 and diabetes mellitus: Given that Oment-1 has anti-inflammatory and antioxidative effects, whereas MALAT1 is associated with proinflammatory activity, our findings suggest a potential regulatory network involving adipokines (e.g., Oment-1) and lncRNAs (e.g., MALAT1) in the pathogenesis of diabetic vascular complications.